(Q33515519)

English

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

8

object named as

Jose Baselga

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

13

object named as

K Kian Ang

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

James A Bonner

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Paul M Harari

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Jordi Giralt

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Roger B Cohen

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Christopher U Jones

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ranjan K Sur

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

David Raben

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sharon A Spencer

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Junming Zhu

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Hagop Youssoufian

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Eric K Rowinsky

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

10 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

21-28

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The evaluation of treatment of patients with extensive squamous cancer of the vocal cords

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative x-ray therapy as an adjunct to radical neck dissection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre‐operative irradiation in the treatment of advanced laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Forest plots: trying to see the wood and the trees

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970311-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(09)70311-0

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33515519&oldid=2109525470"